This month’s round-up from the world of healthcare apps and disruptive technologies includes a personalised treatment app for people with diabetes, mymhealth winning a contact with a CCG, and the growing market of US digital health startups.
Diabetes app treatment secures funding
Cheshire-based company Gendius has secured funding for a digital diabetes treatment.
The digital health start-up has completed a funding round to launch an app-based platform designed to help those living with diabetes better manage their condition. Intellin uses an individual’s clinical history to predict those areas most likely of developing complications from their diabetes i.e. their individual high-risk areas. It then focuses the individual on clinically-validated tasks and measures to slow their progression in these areas. Gendius was founded by Chris Genders and Rory Cameron, who have both previously worked in the pharmaceutical industry.
my mhealth apps to enhance Dorset NHS services
mymhealth have been awarded a contract by Dorset Clinical Commissioning Group (CCG) to provide their digital health apps to patients suffering with diabetes, COPD and heart disease. Working with NHS providers over the next 12 months, my mhealth will introduce the apps myDiabetes, myHeart and myCOPD to at least 1000 patients.